INFINITI MEDICAL AS

3018 DRAMMEN

Finances

Share Ownership

Return on Equity

27,95 %

Current Ratio

1,74

Debt-to-Equity Ratio

0,04

Key figures (NOK)	2022	2021	2020	2019
Revenue	57 330 000	52 951 000	66 626 000	52 199 000
Net Income	3 074 000	4 475 000	9 900 000	4 361 000
Total Assets	26 166 000	24 412 000	29 262 000	11 429 000
Total Equity	10 998 000	10 923 000	10 448 000	9 548 000

Income (NOK)	2022	2021	2020	2019
Revenue	57 330 000	52 951 000	66 626 000	52 199 000
Expenditure	53 318 000	47 227 000	54 028 000	46 717 000
Operating Profit	4 013 000	5 724 000	12 598 000	5 482 000
Financial Income	79 000	39 000	93 000	149 000
Financial Costs	69 000	12 000	13 000	14 000
Financial Balance	10 000	27 000	80 000	135 000
Earnings Before Tax	4 023 000	5 751 000	12 678 000	5 617 000
Tax	948 000	1 276 000	2 777 000	1 255 000
Net Income	3 074 000	4 475 000	9 900 000	4 361 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	425 000	659 000	907 000	132 000
Total Current Assets	25 742 000	23 753 000	28 355 000	11 297 000
Total Assets	26 166 000	24 412 000	29 262 000	11 429 000
Total Retained Equity	10 898 000	10 823 000	10 348 000	9 448 000
Total Equity	10 998 000	10 923 000	10 448 000	9 548 000
Total Long-Term Debt	392 000	499 000	606 000	0
Total Current Debt	14 777 000	12 989 000	18 208 000	1 881 000
Total Equity and Debt	26 166 000	24 412 000	29 262 000	11 429 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	57 317 000	52 951 000	66 626 000	52 199 000
Other Income	13 000	0	0	0
Revenue	57 330 000	52 951 000	66 626 000	52 199 000
Cost of Goods Sold	35 743 000	31 066 000	38 737 000	30 180 000
Salary Costs	10 156 000	10 220 000	9 829 000	8 706 000
Depreciation	235 000	248 000	207 000	132 000
Impairment	0	0	0	0
Expenditure	53 318 000	47 227 000	54 028 000	46 717 000
Operating Profit	4 013 000	5 724 000	12 598 000	5 482 000
Financial Income	79 000	39 000	93 000	149 000
Financial Costs	69 000	12 000	13 000	14 000
Financial Balance	10 000	27 000	80 000	135 000
Dividends	3 000 000	4 000 000	9 000 000	2 300 000
Net Income	3 074 000	4 475 000	9 900 000	4 361 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	425 000	659 000	907 000	132 000
Total Tangible Assets	425 000	659 000	907 000	132 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	425 000	659 000	907 000	132 000
Stock	7 161 000	6 356 000	6 877 000	4 164 000
Total Investments	3 260 000	3 232 000	3 194 000	3 134 000
Cash, Bank	7 829 000	6 726 000	13 453 000	817 000
Total Current Assets	25 742 000	23 753 000	28 355 000	11 297 000
Total Assets	26 166 000	24 412 000	29 262 000	11 429 000
Total Equity	10 998 000	10 923 000	10 448 000	9 548 000
Short-Term Group Debt	4 000 000	0	0	0
Total Long-Term Debt	392 000	499 000	606 000	0
Creditors	1 291 000	3 460 000	2 738 000	1 555 000
Unpaid Taxes	4 371 000	3 113 000	2 468 000	1 930 000
Dividends	3 000 000	4 000 000	9 000 000	2 300 000
Other Current Debt	1 166 000	1 141 000	1 224 000	1 089 000
Total Current Debt	14 777 000	12 989 000	18 208 000	1 881 000
Total Equity and Debt	26 166 000	24 412 000	29 262 000	11 429 000

Financial indicators	2022	2021	2020	2019
Return on Equity	27,95 %	40,97 %	94,75 %	45,67 %
Debt-to-Equity Ratio	0,04	0,05	0,06	0
Operating Profit Margin	7 %	10,81 %	18,91 %	10,5 %
Current Ratio	1,74	1,83	1,56	6,01
Quick Ratio	3,38	3,58	2,5	−4,95
Equity Ratio	0,42	0,45	0,36	0,84
Gross Profit Margin	37,65 %	41,33 %	41,86 %	42,18 %